67 related articles for article (PubMed ID: 33332763)
1. Aneuploidy detection for diagnostic and prognostic use in premalignant and malignant lesions of the uterine cervix: A systematic review.
Costa AF; Ribeiro MGM; Onofre ASC; de Miranda Onofre FB
Diagn Cytopathol; 2021 Feb; 49(2):335-346. PubMed ID: 33332763
[TBL] [Abstract][Full Text] [Related]
2. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
3. The Positive Predictive Value of High-Grade Squamous Intraepithelial Lesion on Cytology for the Histological Diagnosis of Cervical Intraepithelial Neoplasia 2 or Higher: A Systematic Review.
Karia N; Van Loon A; Simoens C; Benoy I; Bogers J
Acta Cytol; 2019; 63(3):206-214. PubMed ID: 30947186
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
[TBL] [Abstract][Full Text] [Related]
5. Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials.
Pileggi C; Flotta D; Bianco A; Nobile CG; Pavia M
Int J Cancer; 2014 Jul; 135(1):166-77. PubMed ID: 24302411
[TBL] [Abstract][Full Text] [Related]
6. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
[TBL] [Abstract][Full Text] [Related]
7. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
8. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia.
Ullal A; Roberts M; Bulmer JN; Mathers ME; Wadehra V
Cytopathology; 2009 Dec; 20(6):359-66. PubMed ID: 18557985
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of cervical dysplasia with DNA image cytometry].
Böcking A; Motherby H
Pathologe; 1999 Jan; 20(1):25-33. PubMed ID: 10091229
[TBL] [Abstract][Full Text] [Related]
10. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Melnikow J; Henderson JT; Burda BU; Senger CA; Durbin S; Weyrich MS
JAMA; 2018 Aug; 320(7):687-705. PubMed ID: 30140883
[TBL] [Abstract][Full Text] [Related]
11. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
12. Nuclear DNA analysis of koilocytic and premalignant lesions of the uterine cervix.
Hughes RG; Neill WA; Norval M
Br Med J (Clin Res Ed); 1987 Jan; 294(6567):267-9. PubMed ID: 3101837
[TBL] [Abstract][Full Text] [Related]
13. [The clinical performance of high risk HPV DNA test among triage women with cytology showing atypical squamous cells of undetermined significance].
Zhang SK; Zhao DM; Chen HM; Guo Z; Ren LY; Jia MM; Chang JJ; Chen PP; Liu SZ; Sun XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Sep; 52(9):941-945. PubMed ID: 30196643
[No Abstract] [Full Text] [Related]
14. Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
Oštrbenk A; Xu L; Arbyn M; Poljak M
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30209184
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs.
Lörincz AT; Richart RM
Arch Pathol Lab Med; 2003 Aug; 127(8):959-68. PubMed ID: 12873167
[TBL] [Abstract][Full Text] [Related]
16. Koilocytotic lesions of the cervix. The relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear DNA content.
Winkler B; Crum CP; Fujii T; Ferenczy A; Boon M; Braun L; Lancaster WD; Richart RM
Cancer; 1984 Mar; 53(5):1081-7. PubMed ID: 6318958
[TBL] [Abstract][Full Text] [Related]
17. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.
Schmitz M; Eichelkraut K; Schmidt D; Zeiser I; Hilal Z; Tettenborn Z; Hansel A; Ikenberg H
BMC Cancer; 2018 Dec; 18(1):1197. PubMed ID: 30509219
[TBL] [Abstract][Full Text] [Related]
18. DNA image cytometry parameters to identify high-grade cervical lesions.
Costa AF; Pogere A; Pasinato APBF; Onofre ASC; Onofre FBM
Cytopathology; 2022 Sep; 33(5):563-571. PubMed ID: 35340056
[TBL] [Abstract][Full Text] [Related]
19. Population-based study of DNA image cytometry as screening method for esophageal cancer.
Zhao L; Wei WQ; Zhao DL; Hao CQ; Lin DM; Pan QJ; Li XQ; Lei FH; Wang JW; Wang GQ; Shang Q; Qiao YL
World J Gastroenterol; 2012 Jan; 18(4):375-82. PubMed ID: 22294844
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
